HIGHLIGHTS
- who: Fabian Patauner and collaborators from the Department of Advanced Medical and Surgical Sciences, University of Campania Luigi Department of Precision Medicine, University of Campania Luigi Vanvitelli, Napoli, Italy have published the research: Safety and Efficacy of Direct Antiviral Agents for Hepatitis C in Patients with Malignancies Other Than Liver Cancer: A Case Series, in the Journal: Pathogens 2022, 11, 860. of 19/06/2022
SUMMARY
Iations. Direct-acting antiviral (DAA) agents are the current standard of care for chronic hepatitis_C and are safe and effective in more than 95% of treated patients . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.